Management of Migraine Using Enerumab and Traditional Therapy at the Time of COVID-19
NCT05052008
·
clinicaltrials.gov ↗
COMPLETED
Status
90
Enrollment
OTHER
Sponsor class
Conditions
Migraine Disorders
Interventions
DRUG:
Erenumab
Sponsor
Fayoum University